Lv6
2160 积分 2020-08-12 加入
9MW2821, a next-generation Nectin-4 targeting antibody-drug conjugate, in patients with advanced solid tumors: a first-in-human, open label, multicenter, phase Ⅰ/Ⅱ study
29天前
已完结
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022
2个月前
已完结
Granulocyte colony-stimulating factor and neutrophils—forgotten mediators of inflammatory disease
3个月前
已完结
Granulocyte Colony–Stimulating Factor Administration: Adverse Events
4个月前
已完结
Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
4个月前
已完结
Short Communication: Renal Tubular Vacuolation in Animals Treated with Polyethylene-Glycol-Conjugated Proteins
4个月前
已完结
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
5个月前
已完结
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
5个月前
已完结
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
5个月前
已完结
Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy
5个月前
已完结
皖公网安备34019202002308
